UNSPSC 51321810: Pirifibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E82B3Z65BN. European Medicines Agency schedules Pirifibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09913MIG. Pirifibrate generally arises in the molecular formula C17H18CLNO4.

UNSPSC 51321810 Pirifibrate is a Commodity-level code covering individual pharmaceutical active ingredients and compounds supplied to state and local health agencies, public hospitals, and emergency services. Recent state and local solicitations under this code show demand for advanced life support medications, generic pharmaceuticals distributed through authorized wholesalers, and direct-to-manufacturer prescription fulfillment arrangements. State and local governments are buying these products primarily for emergency medical services, institutional pharmacy benefit programs, and multistate cooperative purchasing alliances serving public health systems. Issuing bodies include city fire departments and emergency services (Tampa Fire Rescue in Hillsborough County), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local government facilities across member states including Minnesota and Oregon). The scope spans both immediate emergency supplies with short delivery windows and large-scale pharmaceutical sourcing agreements with established wholesaler distribution channels.

Geographic activity centers on Texas, Minnesota, Florida, and Oregon, with multistate cooperative purchasing agreements extending the reach across additional jurisdictions. Representative recent opportunities include the City of Tampa's sealed-bid IFB for Advanced Life Support Medications (26P00188), due April 8, 2026, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with nine-month minimum expiration dates and ten-day delivery requirements ($40,000 estimated value, SLBE sheltered market with 5 percent bid discount); the Minnesota Multistate Cooperative Purchasing Alliance's RFP for Generic Multi Source Pharmaceuticals and OTC Products (S1070000015802), due March 26, 2026, establishing multiple contracts for manufacturer distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson; and the Texas HHS Commission's RFI (HHS0017013) exploring direct-to-manufacturer prescription programs for self-insured group health plans and state agencies. Vendors must comply with FDA requirements, cGMP certification, DSCSA, OSHA Hazard Communication Standards, and WCAG 2.2 accessibility standards. Contract terms typically span one to two years with renewal or extension options.